These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8553846)

  • 21. Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K.
    Sassi ML; Eriksen H; Risteli L; Niemi S; Mansell J; Gowen M; Risteli J
    Bone; 2000 Apr; 26(4):367-73. PubMed ID: 10719280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen.
    Bonde M; Garnero P; Fledelius C; Qvist P; Delmas PD; Christiansen C
    J Bone Miner Res; 1997 Jul; 12(7):1028-34. PubMed ID: 9200001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Collagen cross-linking alterations in joint contractures: changes in the reducible cross-links in periarticular connective tissue collagen after nine weeks of immobilization.
    Akeson WH; Amiel D; Mechanic GL; Woo SL; Harwood FL; Hamer ML
    Connect Tissue Res; 1977; 5(1):15-9. PubMed ID: 141358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular matrix of connective tissues in the heads of teleosts.
    Benjamin M; Ralphs JR
    J Anat; 1991 Dec; 179():137-48. PubMed ID: 1817131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical markers of bone turnover: an update.
    van Daele PL; Birkenhäger JC; Pols HA
    Neth J Med; 1994 Feb; 44(2):65-72. PubMed ID: 8208326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proceedings: Amino-acid composition of insoluble collagen from bones of rachitic and non-rachitic rats.
    Hayashi Y; Takizawa H; Igarashi M; Matsuura M; Yoshino S
    Calcif Tissue Res; 1974; 15(2):170. PubMed ID: 4844413
    [No Abstract]   [Full Text] [Related]  

  • 27. Different responses of free and peptide-bound cross-links to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency.
    Kamel S; Brazier M; Rogez JC; Vincent O; Maamer M; Desmet G; Sebert JL
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3717-21. PubMed ID: 8855828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The collagen of bone.
    Miller EJ; Martin GR
    Clin Orthop Relat Res; 1968; 59():195-232. PubMed ID: 4874882
    [No Abstract]   [Full Text] [Related]  

  • 29. Bone markers, calcium metabolism, and calcium kinetics during extended-duration space flight on the mir space station.
    Smith SM; Wastney ME; O'Brien KO; Morukov BV; Larina IM; Abrams SA; Davis-Street JE; Oganov V; Shackelford LC
    J Bone Miner Res; 2005 Feb; 20(2):208-18. PubMed ID: 15647814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biochemical markers of bone turnover. New aspect. Metabolic bone markers in osteogenesis imperfecta].
    Tanaka H
    Clin Calcium; 2009 Aug; 19(8):1142-7. PubMed ID: 19638698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures.
    Takahara K; Kamimura M; Hashidate H; Uchiyama S; Nakagawa H
    J Orthop Sci; 2007 May; 12(3):219-26. PubMed ID: 17530373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of type I and IV collagens by FT-IR spectroscopy and imaging for a molecular investigation of skeletal muscle connective tissue.
    Petibois C; Gouspillou G; Wehbe K; Delage JP; Déléris G
    Anal Bioanal Chem; 2006 Dec; 386(7-8):1961-6. PubMed ID: 17043797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homocysteine toxicity in connective tissue: theories, old and new.
    Toohey JI
    Connect Tissue Res; 2008; 49(2):57-61. PubMed ID: 18382890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease.
    Brown JE; McCloskey EV; Dewar JA; Body JJ; Cameron DA; Harnett AN; Ruutu M; Purohit OP; Tähtelä R; Coleman RE
    Calcif Tissue Int; 2007 Nov; 81(5):341-51. PubMed ID: 17874331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
    Garnero P; Gineyts E; Riou JP; Delmas PD
    J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A method of isolating the collagen (I) alpha2 chain carboxytelopeptide for species identification in bone fragments.
    Buckley M; Collins M; Thomas-Oates J
    Anal Biochem; 2008 Mar; 374(2):325-34. PubMed ID: 18164255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physico chemical studies on the myocommata of the fish Scomberoides commersonianus.
    Nagamalleswari D; Joseph KT
    Biochem Int; 1990 Dec; 22(6):1041-51. PubMed ID: 2090105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bone resorption marker].
    Kitatani K; Nakatsuka K
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():243-8. PubMed ID: 11979914
    [No Abstract]   [Full Text] [Related]  

  • 39. Urine products of bone breakdown as markers of bone resorption and clinical usefulness of urinary hydroxyproline: an overview.
    Simsek B; Karacaer O; Karaca I
    Chin Med J (Engl); 2004 Feb; 117(2):291-5. PubMed ID: 14975218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in bone mineral density, markers of bone turnover and extracellular matrix and daily life muscular activity among patients with recent motor-incomplete versus motor-complete spinal cord injury.
    Kostovski E; Hjeltnes N; Eriksen EF; Kolset SO; Iversen PO
    Calcif Tissue Int; 2015 Feb; 96(2):145-54. PubMed ID: 25539858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.